Dr. Douglas Simonetto, MD
Claim this profileMayo Clinic
Affiliated Hospitals
Mayo Clinic
Mayo Clinic Minnesota
Clinical Trials Douglas Simonetto, MD is currently running
INT-787
for Alcoholic Hepatitis
This trial tests a new drug called INT-787 for people with severe liver damage from heavy drinking. It aims to see if the drug is safe and effective, and how the body processes it. The goal is to find out if INT-787 can help improve liver health in these patients. Previous studies have shown that similar treatments can protect against liver injury.
Recruiting
0 awards
Phase 2
PHIN-214
for Liver Cirrhosis
This 2-part study will evaluate PHIN-214 given as a single one-time dose (Part 1) and in multiple doses (given as daily doses for 28-days) (in Part 2). Specifically, this study evaluates PHIN-214, to determine the safety, tolerability, and pharmacokinetic effects of PHIN-214, and to establish the maximum tolerated dose or optimal beneficial dose in patients with Child Pugh A and B Cirrhosis.
Recruiting
1 award
Phase 1
2 criteria
More about Douglas Simonetto, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Douglas Simonetto, MD has experience with
- DALC Digital Clinic
- ACE 2.0
- PHIN-214
- BIV201
- Terlipressin
- INT-787
Breakdown of trials Douglas Simonetto, MD has run
Liver Cirrhosis
Fibrosing Colonopathy
Malignant Ascites
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Douglas Simonetto, MD specialize in?
Douglas Simonetto, MD focuses on Liver Cirrhosis and Fibrosing Colonopathy. In particular, much of their work with Liver Cirrhosis has involved treating patients, or patients who are undergoing treatment.
Is Douglas Simonetto, MD currently recruiting for clinical trials?
Yes, Douglas Simonetto, MD is currently recruiting for 2 clinical trials in Rochester Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Douglas Simonetto, MD has studied deeply?
Yes, Douglas Simonetto, MD has studied treatments such as DALC Digital Clinic, ACE 2.0, PHIN-214.
What is the best way to schedule an appointment with Douglas Simonetto, MD?
Apply for one of the trials that Douglas Simonetto, MD is conducting.
What is the office address of Douglas Simonetto, MD?
The office of Douglas Simonetto, MD is located at: Mayo Clinic, Rochester, Minnesota 55905 United States. This is the address for their practice at the Mayo Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.